Literature DB >> 19746754

Acute mastoiditis in children: is computed tomography always necessary?

Sharon Tamir1, Yehuda Schwartz, Uri Peleg, Ronen Perez, Jean-Yves Sichel.   

Abstract

OBJECTIVES: Acute mastoiditis (AM) is the most common intratemporal complication of acute otitis media in children. In the past decade, reports have indicated a rise in the incidence of AM in the pediatric population. A parallel rise in the use of computed tomography (CT) imaging has occurred. The rise in the use of CT scanning in the pediatric population, entraining with it a rise in pediatric brain irradiation, has led us to question the necessity of using CT for pediatric patients with AM.
METHODS: We reviewed the medical files of pediatric patients who had AM in the years 2005 through 2007.
RESULTS: Fifty patients were identified. The gender distribution was equal, and the ages ranged from 4 months to 12 years. Of the 46 patients who were admitted to our institution "de novo," only 2 underwent CT scanning on admission, and 4 other patients had CT performed during hospitalization. The majority of patients (92%) with AM did not have a CT scan performed and were treated conservatively with no complications.
CONCLUSIONS: In most pediatric patients, CT does not seem to be indispensable in the diagnosis of AM. Conservative therapy and close follow-up seem to suffice for most.

Entities:  

Mesh:

Year:  2009        PMID: 19746754     DOI: 10.1177/000348940911800806

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  Dural enhancement and thickening in acute mastoiditis.

Authors:  Shay Shemesh; Tal Marom; Dominique Ben Ami Raichman; Sharon Ovnat Tamir
Journal:  Neuroradiol J       Date:  2015-05-11

2.  Acute mastoiditis in an Italian pediatric tertiary medical center: a 15 - year retrospective study.

Authors:  Claudia Balsamo; Carlotta Biagi; Margherita Mancini; Ilaria Corsini; Rosalba Bergamaschi; Marcello Lanari
Journal:  Ital J Pediatr       Date:  2018-06-18       Impact factor: 2.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.